Stacie brings nearly 20 years of industry experience with expertise in research and development. She has a proven track record of advancing programs to IND for rare disease and oncology indications at companies such as Biogen, bluebird bio, and ElevateBio. Stacie also brings the perspective of being an ALS caregiver, strengthening her commitment to aligning scientific innovation with the real needs of people living with ALS.
